Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Opinion in Molecular Therapeutics|August 19, 2007
Treating HIV-1 infection with dendritic cellsNancy C Connolly, Bonnie A Colleton, Charles R RinaldoAIDS Reviews|November 24, 2005
Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approachesNancy C Connolly, Sharon A Riddler, Charles R RinaldoClinical and Vaccine Immunology : CVI|November 3, 2006
CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cellsAki Hoji, Nancy C Connolly, William G Buchanan, et al.Clinical and Vaccine Immunology : CVI|October 19, 2007
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individualsNancy C Connolly, Theresa L Whiteside, Cara Wilson, et al.Clinical and Vaccine Immunology : CVI|November 29, 2008
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infectionTheresa L Whiteside, Paolo Piazza, Amanda Reiter, et al.Addiction Science & Clinical Practice|May 25, 2023
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort studyMary L Geist, Andrea C Radick, Judith I Tsui, et al.The International Journal on Drug Policy|December 15, 2022
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugsElizabeth J Austin, Alexander J Gojic, Elenore P Bhatraju, et al.Pageof 1